The latest round of Capital Raising may be blurring the lines when it comes to the real reason most here are invested.
The science is strong and Opthea are backing it for 100% ownership to the end. So is the big end of town in particular Regal Funds.
Follow the money!!
https://link.springer.com/article/10.1007/s40123-024-00973-4
- Forums
- ASX - By Stock
- OPT
- Not forgetting the science
Not forgetting the science
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OPT (ASX) to my watchlist
(20min delay)
|
|||||
Last
89.5¢ |
Change
-0.015(1.65%) |
Mkt cap ! $1.101B |
Open | High | Low | Value | Volume |
91.0¢ | 92.0¢ | 87.5¢ | $1.496M | 1.676M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1705 | 89.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
90.5¢ | 46363 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1705 | 0.895 |
1 | 16362 | 0.890 |
1 | 16362 | 0.885 |
2 | 22043 | 0.880 |
5 | 40631 | 0.875 |
Price($) | Vol. | No. |
---|---|---|
0.905 | 46363 | 2 |
0.910 | 62234 | 3 |
0.915 | 26562 | 2 |
0.920 | 543 | 1 |
0.925 | 1239 | 2 |
Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
Featured News
OPT (ASX) Chart |
In this month’s edition of Ophthalmology and Therapy, a scientific review was published about the growing body of evidence that in retinal diseases, such as wet AMD, the pathophysiology is broader than simply dysregulation or overproduction of VEGF-A. Despite the tremendous progress in standard-of-care intravitreal anti-VEGF-A agents, visual gains can be limited in some wet AMD patients, as shown by clinical and real-world studies.
We want to recognize and thank the authors;Ian LeitchMike GeromettaDavid EichenbaumRobert FingerNathan SteinleMegan Baldwin
To read full peer-review article:https://lnkd.in/eu2-_Bdt
Christopher VautrinotSpringer Nature GroupSpringer Healthcare
hashtag#Optheahashtag#maculardegenerationhashtag#AMDResearchhashtag#wetAMDhashtag#ophthalmologyhashtag#medicaleducationhashtag#biopharmahashtag#eyehealthhashtag#retinaspecialistshashtag#sozinibercept